Functions of the extracellular histidine residues of receptor activity-modifying proteins vary within adrenomedullin receptors

Biochemical and Biophysical Research Communications

Volumn 377, Issue 1, 2008, Pages 109-113

  Kuwasako, Kenji ^a   Kitamura, Kazuo ^b   Nagata, Sayaka ^b   Kato, Johji ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Adrenomedullin; Calcitonin receptor like receptor; Flow cytometry; Receptor activity modifying proteins; Receptor mutations; Receptor trafficking

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN RECEPTOR; CALCITONIN RECEPTOR LIKE RECEPTOR; CYCLIC AMP; HETERODIMER; HISTIDINE; RECEPTOR ACTIVITY MODIFYING PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

AMINO ACID SUBSTITUTION; CELL LINE; HISTIDINE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; POINT MUTATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CALCITONIN; RECEPTORS, PEPTIDE;

EID: 54449083954     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.09.105     Document Type: Article

References (23)

1. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H., and Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human Pheochromocytoma. Biochem. Biophys. Res. Commun. 192 (1993) 553-560
2. Shimosawa T., and Fujita T. Adrenomedullin as a potent antioxidative and antiatherosclerotic substance. Drug News Perspect. 18 (2005) 185-189
3. Bunton D.C., Petrie M.C., Hillier C., Johnson F., and McMurray J.J. The clinical relevance of adrenomedullin: a promising profile?. Pharmacol. Ther. 103 (2004) 179-201
4. Poyner D.R., Sexton P.M., Marshall I., Smith D.M., Quirion R., Born W., Muff R., Fischer J.A., and Foord A.M. International union of pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol. Rev. 54 (2002) 233-246
5. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., Solari R., Lee M.G., and Foord S.M. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393 (1998) 333-339
6. Sexton P.M., Albiston A., Morfis M., and Tilakaratne N. Receptor activity modifying proteins. Cell Signal. 13 (2001) 73-83
7. Heroux M., Hougue M., Lemieux S., and Bouvier M. Functional calcitonin gene-related peptide receptors are formed by the asymmetric assembly of a calcitonin receptor-like receptor homo-oligomer and a monomer of receptor activity-modifying protein-1. J. Biol. Chem. 282 (2007) 31610-31620
8. Hilairet S., Belanger C., Bertrand J., Laperriere A., Foord S.M., and Bouvier M. Agonist-promoted internalization of a ternary complex between calcitonin receptor-like receptor, receptor activity-modifying protein 1 (RAMP1), and β-arrestin. J. Biol. Chem. 276 (2001) 29575-29581
9. Muff R., Born W., and Fischer J.A. Adrenomedullin selectivity of calcitonin-like receptor/receptor activity modifying proteins. Hypertens. Res. 26 (2003) S3-S8
10. Kuwasako K., Cao Y.-N., Nagoshi Y., Kitamura K., and Eto T. Adrenomedullin receptors: pharmacological features and possible pathophysiological roles. Peptides 25 (2004) 200302012
11. Kuwasako K., Shimekake Y., Masuda M., Nakahara K., Yoshida T., Kitaura M., Kitamura K., Eto T., and Sakata T. Visualization of the calcitonin receptor-like receptor and its receptor activity-modifying proteins during internalization and recycling. J. Biol. Chem. 275 (2000) 29602-29609
12. Hay D.L., Poyner D.R., and Sexton P.M. GPCR modulation by RAMPs. Pharmacol. Ther. 109 (2006) 173-197
13. Gibbons C., Dackor R., Dunworth W., Fritz-Six K., and Caron K.M. Receptor activity-modifying proteins: RAMPing up adrenomedullin signaling. Mol. Endocrinol. 21 (2007) 783-796
14. Kuwasako K., Kitamura K., Nagoshi Y., Cao Y.N., and Eto T. Identification of the human receptor activity-modifying protein 1 domains responsible for agonist binding specificity. J. Biol. Chem. 278 (2003) 22623-22630
15. Kuwasako K., Kitamura K., Ito K., Uemura T., Yanagita Y., Kato J., Sakata T., and Eto T. The seven amino acids of human RAMP2 (86-92) and RAMP3 (59-65) are critical for agonist binding to human adrenomedullin receptors. J. Biol. Chem. 276 (2001) 49459-49465
16. Kuwasako K., Kitamura K., Onitsuka H., Uemura T., Nagoshi Y., Kato J., and Eto T. Rat RAMP domains involved in adrenomedullin binding specificity. FEBS Lett. 519 (2002) 113-116
17. Christopoulos A., Christopoulos G., Morfis M., Udawela M., Laburthe M., Couvineau A., Kuwasako K., Tilakarayne N., and Sexton P.M. Novel receptor partners and function of receptor activity-modifying proteins. J. Biol. Chem. 278 (2003) 3293-3297
18. Kuwasako K., Cao Y.N., Chu C.P., Iwatsubo S., Eto T., and Kitamura K. Functions of the cytoplasmic tails of the human receptor activity-modifying protein components of calcitonin gene-related peptide and adrenomedullin receptors. J. Biol. Chem. 281 (2006) 7205-7213
19. Kuwasako K., Kitamura K., Uemura T., Nagoshi Y., Kato J., and Eto T. The function of extracellular cysteines in the human adrenomedullin receptor. Hypertens. Res. 26 (2003) S25-S31
20. 69 of the calcitonin-like receptor is required for its functional expression together with receptor-activity-modifying proteins 1 and -2. Biochem. Biophys. Res. Commun. 319 (2004) 1203-1209
21. Flahaut M., Rossier B.C., and Firsov D. Respective roles of calcitonin receptor-like receptor (CRLR) and receptor activity-modifying proteins (RAMP) in cell surface expression of CRLR/RAMP heterodimeric receptors. J. Biol. Chem. 277 (2002) 14731-14737
22. Dong C., Filipeanu C.M., Duvernay M.T., and Wu G. Regulation of G protein-coupled receptor export trafficking. Biochim. Biophys. Acta 1768 (2007) 853-870
23. Rovati G.E., Capra V., and Neubig R.R. The highly conserved DRY motif of class A G protein-coupled receptors: beyond the ground state. Mol. Pharmacol. 71 (2007) 959-964